Furthermore, wound healing assays displayed that the upregulation of XTP6 markedly enhanced the motility of GBM cells, whereas silencing NDH2 expression partially negated these enhancements (Fig. 3R and S3N). The gene discussed is DLEU1; the disease is glioblastoma.